- Home
- BBCP vs JSPR Comparison
BBCP vs JSPR Comparison
Compare BBCP & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBCP | JSPR |
|---|---|---|
| Founded | 1983 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.0M | 68.4M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | BBCP | JSPR |
|---|---|---|
| Price | $6.94 | $1.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $7.50 | ★ $25.60 |
| AVG Volume (30 Days) | 110.1K | ★ 3.8M |
| Earning Date | 01-07-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $395,562,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.28 | N/A |
| P/E Ratio | $42.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.78 | $1.39 |
| 52 Week High | $9.68 | $23.11 |
Technical Indicators
Market Signals| Indicator | BBCP | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 66.46 | 46.29 |
| Support Level | $6.29 | $1.60 |
| Resistance Level | $6.92 | $1.93 |
| Average True Range (ATR) | 0.32 | 0.20 |
| MACD | 0.09 | 0.03 |
| Stochastic Oscillator | 98.18 | 36.90 |
Price Performance
Historical ComparisonAbout BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators position it to deliver concrete placement solutions. The company's operating segment includes U.S. Concrete Pumping; U.K. Operations; U.S. Concrete Waste Management Services and Corporate. It generates maximum revenue from the U.S. Concrete Pumping segment. Geographically, it generates majority of the revenue from its business in United States.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.